Evaluation of Prescription of Cases of Gerd Acid Disorders in Patients at Kasatria Public Health Center, Pematang Siantar City
Main Article Content
Abstract
In the treatment of cases of stomach acid disorders, single therapy is usually used, but there are some who use combination therapy. Usually the drugs used in combination therapy are given based on the severity of stomach acid disorders. From the study it was found that the profile of the use of gastric acid disorders or a combination of drugs was as follows: acid reflux drugs or a combination of many were used in patients with gastritis and dyspepsia, based on age the most widely treated drugs for stomach acid disorders or a combination were the age range of 44-45 years (28%), the administration of drugs for stomach acid disorders or combinations related to clinical symptoms was the most common being dizziness and nausea and the most used was the combination of antacids + Ranitidine + Sucralfate, the duration of administration of drugs for stomach acid disorders or combinations was in the range of less than 7 days and DRP ( Potential Drug Related Problems found are interactions between Omeprazole and Diazepam, Omeprazole and Vitamin B12. There is no administration of drug doses for stomach acid disorders or combinations that exceed the doses suggested by Liberatur.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Alhazzani, W., Alshahrani, M., Moayyedi, P., Jaeschke, R. 2012. Stress Ulcer Prophylaxis in Critically Ill Patients: Review of the evidence. Canada: Departments of Medicine, McMaster University, Hamilton, Polish Archives of Internal Medicine.
Anonymous. 2008. British National Formulary Ed.56th. BMJ Group and RPS Publishing.
Anonymous, 2012. List and ceiling of drug prices . Jakarta: PT. ASKES Indonesia.
Bertram G., Katzung 2007. Basic and Clinical Pharmacology Ed., 9th. USA Lange Medical Books/McGraw Hill.
Bitar K., Greenwood-Van Meerveld B., Sand R., Wiley JW 2011. Aging and Gastrointestinal Neuromuscular Function: Insights from Within and Outside the Gut. Motile Neurogastroenterol. 2011 June, 23(6): 490-501.
Camilleri, M., Bharucha, AE, Farrugia, G. 2011. Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis . Minnesota Clinical Enteric Neuroscience Translational and Epidemiological Research Clinical Gastroenterology And Hepatology 2011;9:5-12
Carceller, DB, Terraz, PB, Vernis, MM, Paris, AS, Aznar, P. Trincado, Gamboa, RA 2011 Are proton pump inhibitors a new antidiabetic drug? A cross-sectional study. Spain: Hospital Miguel Servet, Zaragoza World J Diabetes 2011 December 15, 2012): 217-220.
Chiba, M., Sugawara, T., Tozawa, H., Tsuda, H., Abe, T., Tokairin, T., Ono 1, Ushiyama, E. 2009. Lansoprazole-Associated Collagenous Colitis: Diffuse Mucosal Cloudiness Mimicking Ulcerative Colitis. Japan World J Gastroenterol. 2009 May 7; 15(17): 2166-2169.
Crawford, JM and Liu, C., 2005, The Gastrointestinal Tract In Kumar, V., Abbas, AK, Fausto, N. Robbins and Cottran Pathologic Basis of Disease. Philadelphia: Elsevier Inc., p. 810.
Pakhomova, I. & Malko-Skroz, M.. (2020). Differentiated approach to the choice of PPI in a patient with GERD in the practice of an outpatient (with a clinical case). Meditsinskiy sovet = Medical Council. 20-26. 10.21518/2079-701X-2020-15-20-26.
Hassall, Eric. (2012). Over-Prescription of Acid-Suppressing Medications in Infants: How It Came About, Why It's Wrong, and What to Do About It. The Journal of pediatrics. 160. 193-8. 10.1016/j.jpeds.2011.08.067.
Oparin, Oleksiy & Khomenko, Liudmyla & Dvoyashkina, Yuliia & Sergienko, Olena & Kochueva, Maryna & Morozova, Olga & Pavlov, Sergey. (2022). MECHANISMS OF THE FORMATION OF MOTOR-SECRETORY DISORDERS IN PATIENTS WITH GERD WITH CONCOMITANT AIT. Wiadomości Lekarskie. 75. 223-227. 10.36740/WLek202201213.
Cheng, Yu-Hsien & Tung, Tao-Hsin & Chen, Pei-En & Tsai, Ching-Yao. (2020). Risk of incident gastroesophageal reflux disease (GERD) in patients with sleep disorders: a population-based cohort study. Sleep and Biological Rhythms. 19. 1-7. 10.1007/s41105-020-00282-w.
Cheng, Yu-Hsien & Chen, Pei-En & Chien, Ching Wen & Tung, Tao-Hsin. (2020). Risk of incident gastroesophageal reflux disease (GERD) in patients with sleep disorders: A population-based cohort study. 10.21203/rs.3.rs-19848/v1.
Sato, Keigo & Inagaki, Risa & Michikawa, Takehiro & Kawabata, Soya & Ito, Kaori & Morita, Mitsuhiro & Hayakawa, Kazue & Kaneko, Shinjiro & Yamada, Shigeki & Fujita, Nobuyuki. (2021). Prescription drug survey of elderly patients with degenerative musculoskeletal disorders. Geriatrics & Gerontology International. 22. 10.1111/ggi.14326.
Hill, Charles & Versluijs, Yvonne & Furay, Elisa & Reese-White, Deonna & Holan, Cole & Alexander, Jeremiah & Doggett, Stephanie & Ring, David & Buckley, Francis. (2021). Psychoemotional factors and their influence on the quality of life in patients with GERD. Surgical Endoscopy. 35. 1-8. 10.1007/s00464-020-08145-8.
Paireder, M. & Kristo, Ivan & Asari, Reza & Jomrich, Gerd & Steindl, Johannes & Rieder, Erwin & Schoppmann, Sebastian. (2021). Effect of electrical stimulation therapy of the lower esophageal sphincter in GERD patients with ineffective esophageal motility. Surgical Endoscopy. 35. 1-7. 10.1007/s00464-020-08104-3.
Uno, Kosuke & Saito, Koichiro & Yabe, Haruna & Kono, Takeyuki & Ogawa, Kaoru. (2016). Clinical Review of Globus Patients with a Focus on GERD Cases. Nihon Jibiinkoka Gakkai kaiho. 119. 1388-1396.
De Bortoli, Nicola & Natali, Veronica & Melissari, Sara & Simonetti, Natalia & Tapete, Gherardo & Marchi, Santino. (2017). Overlap of GERD and gastrointestinal functional disorders. Minerva gastroenterologica e dietologica. 63. 10.23736/S1121-421X.17.02398-4.
Greer, Katarina. (2022). Management of GERD in Patients With Obesity. Foregut: The Journal of the American Foregut Society. 1. 263451612110667. 10.1177/26345161211066792.
Siregar, Rahmah & Yusuf, Susi & Fernaldy, Devrich. (2022). The Relationship between Physical Conditions of the House and the Incidence of Tuberculosis. International Journal of Public Health Excellence (IJPHE). 1. 01-05. 10.55299/ijphe.v1i1.2.